NV
Novacyt S.A.
NVYTF · OTC
$0.57 -0.09% (-$0.00)
Market Cap £31.0M
P/E Ratio -
Div. Yield -
ROE 96.86%
Bulios Fair Price
$0.36
36.9% downside
Trenutna cena
$0.57
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NVYTF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
99 /100
Cheap P/B 1.33x
P/S 1.23x
EV/EBITDA N/A
Growth
12 /100
Declining Book val. growth 41.29%
Rev. growth 1.04%
FCF growth N/A
Profitability
20 /100
Weak Net margin 123.80%
Op. margin 96.16%
FCF margin 43.29%
Quality
8 /100
Poor ROE 96.86%
ROA 77.60%
Asset turnover 0.63x
Debt
64 /100
Moderate Current ratio 4.74x
Int. coverage -23.42x
Debt/Equity 0.45x
Stability
31 /100
Unstable Rev. volatility 57.46%
EPS volatility 48.42%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NVYTF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Lyn Dafydd Rees
Employees
234
Headquarters
Le Vésinet
Prihajajoči dogodki
24 SEP.
Earnings
Upcoming earnings report